Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer

CAMBRIDGE, Massachusetts and BASEL, Switzerland, Feb. 21, 2019 -- (Healthcare Sales & Marketing Network) -- Enzyvant, a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases, today announced the appointme... Biopharmaceuticals, Personnel Enzyvant, immunodeficiency
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news